Symbol: |
OTOA
|
Description: |
otoancorin [Source:HGNC Symbol;Acc:16378]
|
Location: |
Chr16:21689835-21772050[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:166
Gene |
Compound |
Gen_sig |
Exp_pattern |
OTOA |
NSC 405789 |
0.019 |
Up |
OTOA |
NSC 49789 |
0.027 |
Up |
OTOA |
NSC 57958 |
0.029 |
Up |
OTOA |
NSC 58903 |
0.004 |
Up |
OTOA |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.031 |
Up |
OTOA |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.02 |
Up |
OTOA |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.045 |
Up |
OTOA |
NSC 632780 |
0.017 |
Up |
OTOA |
Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride |
0.012 |
Up |
OTOA |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride |
0.024 |
Up |
OTOA |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.024 |
Up |
OTOA |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.036 |
Up |
OTOA |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.012 |
Up |
OTOA |
NSC 641594 |
0.02 |
Up |
OTOA |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.013 |
Up |
Expression pattern: Sensitivity / Resistance
Total:12 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:9
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:55
Total:4 Current:1
[First] [Prev]  Next Last 
|